Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in HIV Wasting Syndrome
NCT00002127Phase 2Completed
- Sponsor
- Celgene Corporation
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in HIV wasting syndrome, sponsored by Celgene Corporation. Status: completed.
02
Drugs
thalidomide
03
Conditions
HIV wasting syndrome
Beyond the preview
Go deeper on NCT00002127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002127.